Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Bonaventure

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
The Journal of Biological Chemistry|July 4, 2007
R3(BDelta23 27)R/I5 chimeric peptide, a selective antagonist for GPCR135 and GPCR142 over relaxin receptor LGR7: in vitro and in vivo characterizationChester Kuei, Steven Sutton, Pascal Bonaventure, et al.
Annals of the New York Academy of Sciences|May 7, 2009
Relaxin family peptides and receptors in mammalian brainAndrew L Gundlach, Sherie Ma, Qian Sang, et al.
ACS Medicinal Chemistry Letters|October 16, 2020
Substituted Azabicyclo[2.2.1]heptanes as Selective Orexin-1 Antagonists: Discovery of JNJ-54717793Cathy Préville, Pascal Bonaventure, Tatiana Koudriakova, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Synthesis and Pharmacological Characterization of Two Novel, Brain Penetrating P2X7 AntagonistsMichael A Letavic, Brian Lord, Francois Bischoff, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 10, 2012
Translational evaluation of JNJ-18038683, a 5-hydroxytryptamine type 7 receptor antagonist, on rapid eye movement sleep and in major depressive disorderPascal Bonaventure, Christine Dugovic, Michelle Kramer, et al.
Journal of Medicinal Chemistry|June 19, 2015
Novel Octahydropyrrolo[3,4-c]pyrroles Are Selective Orexin-2 Antagonists: SAR Leading to a Clinical CandidateMichael A Letavic, Pascal Bonaventure, Nicholas I Carruthers, et al.
Bioorganic & Medicinal Chemistry Letters|April 13, 2010
Novel substituted pyrrolidines are high affinity histamine H3 receptor antagonistsEmily M Stocking, Leah Aluisio, John R Atack, et al.
Translational Psychiatry|September 8, 2020
Translational evaluation of novel selective orexin-1 receptor antagonist JNJ-61393215 in an experimental model for panic in rodents and humansGiacomo Salvadore, Pascal Bonaventure, Anantha Shekhar, et al.
Journal of Medicinal Chemistry|February 17, 2025
Design, Synthesis, and Characterization of GluN2A Negative Allosteric Modulators Suitable for In Vivo ExplorationFrançois P Bischoff, Sven Van Brandt, Marcel Viellevoye, et al.
Bioorganic & Medicinal Chemistry Letters|November 28, 2006
Novel tetrahydroisoquinolines are histamine H3 antagonists and serotonin reuptake inhibitorsMichael A Letavic, John M Keith, Jill A Jablonowski, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
The Journal of Biological Chemistry|July 4, 2007
R3(BDelta23 27)R/I5 chimeric peptide, a selective antagonist for GPCR135 and GPCR142 over relaxin receptor LGR7: in vitro and in vivo characterizationChester Kuei, Steven Sutton, Pascal Bonaventure, et al.
Annals of the New York Academy of Sciences|May 7, 2009
Relaxin family peptides and receptors in mammalian brainAndrew L Gundlach, Sherie Ma, Qian Sang, et al.
ACS Medicinal Chemistry Letters|October 16, 2020
Substituted Azabicyclo[2.2.1]heptanes as Selective Orexin-1 Antagonists: Discovery of JNJ-54717793Cathy Préville, Pascal Bonaventure, Tatiana Koudriakova, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Synthesis and Pharmacological Characterization of Two Novel, Brain Penetrating P2X7 AntagonistsMichael A Letavic, Brian Lord, Francois Bischoff, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 10, 2012
Translational evaluation of JNJ-18038683, a 5-hydroxytryptamine type 7 receptor antagonist, on rapid eye movement sleep and in major depressive disorderPascal Bonaventure, Christine Dugovic, Michelle Kramer, et al.
Journal of Medicinal Chemistry|June 19, 2015
Novel Octahydropyrrolo[3,4-c]pyrroles Are Selective Orexin-2 Antagonists: SAR Leading to a Clinical CandidateMichael A Letavic, Pascal Bonaventure, Nicholas I Carruthers, et al.
Bioorganic & Medicinal Chemistry Letters|April 13, 2010
Novel substituted pyrrolidines are high affinity histamine H3 receptor antagonistsEmily M Stocking, Leah Aluisio, John R Atack, et al.
Translational Psychiatry|September 8, 2020
Translational evaluation of novel selective orexin-1 receptor antagonist JNJ-61393215 in an experimental model for panic in rodents and humansGiacomo Salvadore, Pascal Bonaventure, Anantha Shekhar, et al.
Journal of Medicinal Chemistry|February 17, 2025
Design, Synthesis, and Characterization of GluN2A Negative Allosteric Modulators Suitable for In Vivo ExplorationFrançois P Bischoff, Sven Van Brandt, Marcel Viellevoye, et al.
Bioorganic & Medicinal Chemistry Letters|November 28, 2006
Novel tetrahydroisoquinolines are histamine H3 antagonists and serotonin reuptake inhibitorsMichael A Letavic, John M Keith, Jill A Jablonowski, et al.
Pageof 10